Drug intelligence / Profile preview

Base Cream

Development stage: Unknown
Lead developer: Wright State University
Modality: Hydrogel Systems → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
Administration: Topical

Overview

Base Cream refers to the topical vehicle formulation used as a comparator in clinical research conducted by Wright State University, specifically in studies targeting photosensitivity. In these trials, such as those investigating the effects of topical imipramine on ultraviolet B (UVB) induced microvesicle particle release and erythema, the base cream serves as a placebo control. It is designed to be pharmacologically inactive, allowing researchers to isolate the therapeutic effects of the active ingredient from the physical properties of the cream's application, such as skin hydration or barrier protection.

Other names: Vehicle

Beyond the preview

Go deeper on Base Cream.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Base Cream.

Explore the full profile